Clinical features of nosocomial infections by extended-spectrum β-lactamase-producing Enterobacteriaceae in neonatal intensive care units

被引:13
作者
Chiu, S
Huang, YC
Lien, RI
Chou, YH
Lin, TY
机构
[1] Chang Gung Childrens Hosp, Div Pediat Infect Dis, Taoyuan 333, Taiwan
[2] Chang Gung Childrens Hosp, Div Neonatol, Taoyuan 333, Taiwan
[3] Chang Gung Univ, Taoyuan, Taiwan
关键词
extended-spectrum beta-lactamase; neonatal intensive care unit; Klebsiella pneumoniae; Escherichia coli; carbapenem;
D O I
10.1080/08035250510037704
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To determine the risk factors for the acquisition of nosocomial extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae infection in infants hospitalized in neonatal intensive care units (NICUs) and to evaluate the therapeutic outcome of these infants. Methods: We retrospectively reviewed the medical records of infants with nosocomial ESBL-producing Enterobacteriaceae infection hospitalized in NICUs at Chang Gung Children's Hospital in 2001. The clinical features of these infants were compared with a cohort of non-ESBL-producing Enterobacteriaceae-infected infants during the same period. The therapeutic outcome of the infants in the ESBL group was analysed. Results: Seventy infants were included in this study. Thirty-one infants with 34 isolates were identified in the ESBL group and 39 infants with 42 isolates in the non-ESBL group. Of the parameters analysed, including gestational age, birthweight, length of hospital stay before onset, the number of antibiotics used, the duration of third-generation cephalosporin usage and the number of patients receiving a third-generation cephalosporin prior to the onset of infection, no significant difference was found between the two groups. The infection-contributed case fatality rate was 3.0% (1 of 33) in the ESBL group, not significantly different from that in the non-ESBL group (1 of 41, 2.4%). Of the 31 patients in the ESBL group, 18 were treated with a carbapenem as definitive therapy while 13 were treated with a non-carbapenem antibiotic regimen. No significant difference was noted in terms of mortality rate between the two subgroups. Conclusion: The outcome of the infants hospitalized in the NICU with ESBL-producing enterobacterial infections was not indispensably grave, even when treated with a non-carbapenem antibiotic regimen. The risk factors for the acquisition of ESBL-producing enterobacterial infections in these infants were not identified in this series.
引用
收藏
页码:1644 / 1649
页数:6
相关论文
共 28 条
[1]  
[Anonymous], M100S11 NCCLS
[2]  
[Anonymous], 2000, M2A7 NCCLS
[3]   MOLECULAR EPIDEMIOLOGY OF KLEBSIELLA-PNEUMONIAE STRAINS THAT PRODUCE SHV-4 BETA-LACTAMASE AND WHICH WERE ISOLATED IN 14 FRENCH HOSPITALS [J].
ARLET, G ;
ROUVEAU, M ;
CASIN, I ;
BOUVET, PJM ;
LAGRANGE, PH ;
PHILIPPON, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2553-2558
[4]   MOLECULAR EPIDEMIOLOGY OF PLASMID SPREAD AMONG EXTENDED BROAD-SPECTRUM BETA-LACTAMASE-PRODUCING KLEBSIELLA-PNEUMONIAE ISOLATES IN A PEDIATRIC HOSPITAL [J].
BINGEN, EH ;
DESJARDINS, P ;
ARLET, G ;
BOURGEOIS, F ;
MARIANIKURKDJIAN, P ;
LAMBERTZECHOVSKY, NY ;
DENAMUR, E ;
PHILIPPON, A ;
ELION, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) :179-184
[5]   Clinical and bacteriologic epidemiology of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit [J].
Decré, D ;
Gachot, B ;
Lucet, JC ;
Arlet, G ;
Bergogne-Bérézin, E ;
Régnier, B .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :834-844
[6]   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection:: risk factors and clinical outcome [J].
Du, B ;
Long, Y ;
Liu, HZ ;
Chen, DC ;
Liu, DW ;
Xu, YC ;
Xie, XL .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1718-1723
[7]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[8]   Prevalence of extended-spectrum β-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital [J].
Jain, A ;
Roy, I ;
Gupta, MK ;
Kumar, M ;
Agarwal, SK .
JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (05) :421-425
[9]   Treatment failure due to extended spectrum beta-lactamase [J].
Karas, JA ;
Pillay, DG ;
Muckart, D ;
Sturm, AW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :203-204
[10]   Outbreak of infections caused by Enterobacter cloacae producing the integron-associated β-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital [J].
Kartali, G ;
Tzelepi, E ;
Pournaras, S ;
Kontopoulou, C ;
Kontos, F ;
Sofianou, D ;
Maniatis, AN ;
Tsakris, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1577-1580